Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 2
2000 1
2006 1
2008 1
2009 4
2010 16
2011 11
2012 6
2013 4
2014 3
2015 4
2016 7
2017 6
2018 8
2019 14
2020 23
2021 31
2022 39
2023 35
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Author Reply.
de Barros HA, van Leeuwen PJ, van der Poel HG. de Barros HA, et al. Among authors: van leeuwen pj. Urology. 2022 Oct;168:163-164. doi: 10.1016/j.urology.2022.04.045. Urology. 2022. PMID: 36266020 No abstract available.
Reply by Authors.
Doan P, Scheltema MJ, Amin A, Shnier R, Geboers B, Gondoputro W, Moses D, van Leeuwen PJ, Haynes AM, Matthews J, Brenner P, O'Neill G, Yuen C, Delprado W, Stricker P, Thompson J. Doan P, et al. Among authors: van leeuwen pj. J Urol. 2022 Nov;208(5):1036. doi: 10.1097/JU.0000000000002885.02. Epub 2022 Sep 12. J Urol. 2022. PMID: 36094874 No abstract available.
Editorial Comment.
Stricker PD, Van Leeuwen PJ. Stricker PD, et al. Among authors: van leeuwen pj. J Urol. 2019 Jun;201(6):1142. doi: 10.1097/01.JU.0000554684.52942.bc. J Urol. 2019. PMID: 30870068 No abstract available.
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial.
Stibbe JA, de Barros HA, Linders DGJ, Bhairosingh SS, Bekers EM, van Leeuwen PJ, Low PS, Kularatne SA, Vahrmeijer AL, Burggraaf J, van der Poel HG. Stibbe JA, et al. Among authors: van leeuwen pj. Lancet Oncol. 2023 May;24(5):457-467. doi: 10.1016/S1470-2045(23)00102-X. Epub 2023 Apr 14. Lancet Oncol. 2023. PMID: 37062295 Clinical Trial.
Reply by Authors.
Meijer D, Luiting HB, van Leeuwen PJ, Remmers S, Jansen BHE, Bodar YJL, Witteveen T, Schaake EE, van der Poel HG, Wondergem M, Busstra MB, Nieuwenhuijzen JA, Meijnen P, Brabander T, van Moorselaar RJA, Hendrikse NH, Oprea-Lager DE, Roobol MJ, Vis AN. Meijer D, et al. Among authors: van leeuwen pj. J Urol. 2021 Apr;205(4):1108-1109. doi: 10.1097/JU.0000000000001437.02. Epub 2021 Jan 25. J Urol. 2021. PMID: 33493004 No abstract available.
Reply by Authors.
Meijer D, de Barros HA, van Leeuwen PJ, Bodar YJL, van der Poel HG, Donswijk ML, Hendrikse NH, van Moorselaar RJA, Nieuwenhuijzen JA, Oprea-Lager DE, Vis AN. Meijer D, et al. Among authors: van leeuwen pj. J Urol. 2021 Jun;205(6):1662. doi: 10.1097/JU.0000000000001592.02. Epub 2021 Mar 18. J Urol. 2021. PMID: 33734856 No abstract available.
Reply by Authors.
Luiting HB, van Leeuwen PJ, Remmers S, Donswijk M, Busstra MB, Bakker IL, Brabander T, Stokkel M, van der Poel HG, Roobol MJ. Luiting HB, et al. Among authors: van leeuwen pj. J Urol. 2020 Sep;204(3):510. doi: 10.1097/JU.0000000000001012.02. Epub 2020 Jun 26. J Urol. 2020. PMID: 32589489 No abstract available.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
Reply by Authors.
Veerman H, Houwink API, Schutte PFE, Nieuwenhuijzen JA, Roeleveld TA, Wit E, Mazel JW, van der Sluis TM, Vis AN, van Leeuwen PJ, van der Poel HG. Veerman H, et al. Among authors: van leeuwen pj. J Urol. 2021 Jun;205(6):1680. doi: 10.1097/JU.0000000000001645.02. Epub 2021 Mar 18. J Urol. 2021. PMID: 33734854 No abstract available.
185 results